Elipovimab
Elipovimab is a potent broadly neutralizing HIV-1 antibody for the targeted elimination of HIV-infected cells[1]
Product Specifications
CAS Number
2101210-43-7
UNSPSC
12352203
Target
HIV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/elipovimab.html
Purity
97.64
Solubility
10 mM in DMSO
Smiles
[Elipovimab]
Molecular Weight
(146.72 kDa)
References & Citations
[1]Caroline Thue Hvilsom, et al. TLR-Agonist Mediated Enhancement of Antibody-Dependent Effector Functions as Strategy For an HIV-1 Cure. Front Immunol. 2021 Sep 23;12:704617.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
DZ41832-Fluoro488 200 µL/Vial
Anti-Aedes aegypti (Yellowfever mosquito) AePuck Antibody Fluoro488 Conjugated
Sign In for Pricing
View Details